Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Detection of EGFR T790M mutation using liquid biopsy for non-small cell lung cancer: Utility of droplet digital polymerase chain reaction vs. cobas real-time polymerase chain reaction.
Zungsontiporn N, Ouwongprayoon P, Boonsirikamchai P, Leelayuwatanakul N, Vinayanuwattikun C, Moonai K, Khongkhaduead E, Thorner PS, Shuangshoti S, Teerapakpinyo C. Zungsontiporn N, et al. Among authors: leelayuwatanakul n. Pathol Res Pract. 2024 Mar;255:155213. doi: 10.1016/j.prp.2024.155213. Epub 2024 Feb 16. Pathol Res Pract. 2024. PMID: 38394807
Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer.
Sitthideatphaiboon P, Teerapakpinyo C, Korphaisarn K, Leelayuwatanakul N, Pornpatrananrak N, Poungvarin N, Chantranuwat P, Shuangshoti S, Aporntewan C, Chintanapakdee W, Sriuranpong V, Vinayanuwattikun C. Sitthideatphaiboon P, et al. Among authors: leelayuwatanakul n. Sci Rep. 2022 Feb 9;12(1):2167. doi: 10.1038/s41598-022-06239-y. Sci Rep. 2022. PMID: 35140316 Free PMC article.
Multimodality treatment in immunocompromised patients with severe COVID-19: the role of IL-6 inhibitor, intravenous immunoglobulin, and haemoperfusion.
Leelayuwatanakul N, Kongpolprom N, Sriprasart T, Phoophiboon V, Thanthitaweewat V, Thawanaphong S, Sirichana W, Chirakalwasan N, Kawkitinarong K, Sittipunt C, Putcharoen O, Paitoonpong L, Suwanpimolkul G, Jantarabenjakul W, Srisawat N, Pachinburavan M. Leelayuwatanakul N, et al. Respirol Case Rep. 2021 Mar 7;9(4):e0733. doi: 10.1002/rcr2.733. eCollection 2021 Apr. Respirol Case Rep. 2021. PMID: 33732466 Free PMC article.
Endotoxemia and circulating bacteriome in severe COVID-19 patients.
Sirivongrangson P, Kulvichit W, Payungporn S, Pisitkun T, Chindamporn A, Peerapornratana S, Pisitkun P, Chitcharoen S, Sawaswong V, Worasilchai N, Kampunya S, Putcharoen O, Thawitsri T, Leelayuwatanakul N, Kongpolprom N, Phoophiboon V, Sriprasart T, Samransamruajkit R, Tungsanga S, Tiankanon K, Lumlertgul N, Leelahavanichkul A, Sriphojanart T, Tantawichien T, Thisyakorn U, Chirathaworn C, Praditpornsilpa K, Tungsanga K, Eiam-Ong S, Sitprija V, Kellum JA, Srisawat N. Sirivongrangson P, et al. Among authors: leelayuwatanakul n. Intensive Care Med Exp. 2020 Dec 7;8(1):72. doi: 10.1186/s40635-020-00362-8. Intensive Care Med Exp. 2020. PMID: 33284413 Free PMC article.
Feasibility Technique of Low-passage In Vitro Drug Sensitivity Testing of Malignant Pleural Effusion from Advanced-stage Non-small Cell Lung Cancer for Prediction of Clinical Outcome.
Vinayanuwattikun C, Prakhongcheep O, Tungsukruthai S, Petsri K, Thirasastr P, Leelayuwatanakul N, Chanvorachote P. Vinayanuwattikun C, et al. Among authors: leelayuwatanakul n. Anticancer Res. 2019 Dec;39(12):6981-6988. doi: 10.21873/anticanres.13920. Anticancer Res. 2019. PMID: 31810970
11 results